Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Germain

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Nature Communications|March 31, 2021
Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPsKiran Todkar, Lilia Chikhi, Véronique Desjardins, et al.
Transfusion|August 1, 2017
Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approachMarc Germain, Gilles Delage, Sheila F O'Brien, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 26, 2024
Incidence of SARS-CoV-2 during the Omicron wave: Results of a longitudinal serosurvey in Québec, CanadaAntoine Lewin, Marc Germain, Renée Bazin, et al.
Transfusion|March 17, 2017
Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012Gilles Delage, Sophie Dubuc, Yves Grégoire, et al.
Oncogene|November 25, 2003
Regulation of apoptosis by endoplasmic reticulum pathwaysDavid G Breckenridge, Marc Germain, Jaigi P Mathai, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 9, 2025
Blood banks saving sight: collaboration for successful treatment of ligneous conjunctivitisEileen Javidi, Simon Javidi, Patrick Hamel, et al.
Vox Sanguinis|August 10, 2019
'One step closer': Acceptability of a programme of plasma donation for fractionation from men who have sex with menJessica Caruso, Marc Germain, Gaston Godin, et al.
Transfusion|May 13, 2022
Cost-effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogensYves Grégoire, Gilles Delage, Brian Custer, et al.
Transfusion|October 17, 2025
HBV deferrals and NAT window period: Assessing the impact of 3-month versus 4-month testing delaysAntoine Lewin, Marc Germain, Sylvie Lachance, et al.
Transfusion|October 31, 2022
Validation of new, gender-neutral questions on recent sexual behaviors among plasma donors and men who have sex with menAntoine Lewin, Christian Renaud, Marc Germain, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Nature Communications|March 31, 2021
Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPsKiran Todkar, Lilia Chikhi, Véronique Desjardins, et al.
Transfusion|August 1, 2017
Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approachMarc Germain, Gilles Delage, Sheila F O'Brien, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 26, 2024
Incidence of SARS-CoV-2 during the Omicron wave: Results of a longitudinal serosurvey in Québec, CanadaAntoine Lewin, Marc Germain, Renée Bazin, et al.
Transfusion|March 17, 2017
Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012Gilles Delage, Sophie Dubuc, Yves Grégoire, et al.
Oncogene|November 25, 2003
Regulation of apoptosis by endoplasmic reticulum pathwaysDavid G Breckenridge, Marc Germain, Jaigi P Mathai, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 9, 2025
Blood banks saving sight: collaboration for successful treatment of ligneous conjunctivitisEileen Javidi, Simon Javidi, Patrick Hamel, et al.
Vox Sanguinis|August 10, 2019
'One step closer': Acceptability of a programme of plasma donation for fractionation from men who have sex with menJessica Caruso, Marc Germain, Gaston Godin, et al.
Transfusion|May 13, 2022
Cost-effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogensYves Grégoire, Gilles Delage, Brian Custer, et al.
Transfusion|October 17, 2025
HBV deferrals and NAT window period: Assessing the impact of 3-month versus 4-month testing delaysAntoine Lewin, Marc Germain, Sylvie Lachance, et al.
Transfusion|October 31, 2022
Validation of new, gender-neutral questions on recent sexual behaviors among plasma donors and men who have sex with menAntoine Lewin, Christian Renaud, Marc Germain, et al.
Pageof 14